Trigger release liposome systems: local and remote controlled delivery?

References

• Abramowicz JS. Ultrasound contrast media and their use in obstetrics and gynecology. Ultrasound Med Biol 1997; 23: 1287–98
   PubMedGoogle Scholar
• Allen TM. Liposomal drug delivery. Curr Opin Colloid Interface Sci 1996; 1: 645–51
   Web of Science ®Google Scholar
• Allen TM, Hansen CB, Menezes D. Pharmacokinetics of long circulating liposomes. Adv Drug Deliv Rev 1995; 16: 267–84
   Web of Science ®Google Scholar
• Arni RK, Ward RJ. Phospholipase A2 – a structural review. Toxicon 1996; 34: 827–41
   PubMed Web of Science ®Google Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238–52
   PubMed Web of Science ®Google Scholar
• Basanez G, Ruiz-Argüello MB, Alonso A, Goni FM, Karlson G, Edwards K. Morphological changes induced by phospholipase C and by Sphingomyelinase on large unilamellar vesicles: A Cryo-Transmission electron microscopy study on liposome fusion. Biophys J 1997; 72: 2630–7
   PubMedGoogle Scholar
• Birkedal-Hasen H, Moore WG, Bodden MK, Windsor LJ, Birkedal HB, DeCarlo A, Engler J. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993; 4: 197–250
   PubMedGoogle Scholar
• Calliada F, Campani R, Bottinelli O, Bozin A, Sommaruga MG. Ultrasound contrast agents: Basic principles. Eur J Radiol 1998; 27: S157–60
   Google Scholar
• Chandaroy P, Sen A, Hui SW. Temperature controlled contents release from liposomes encapsulating pluronic F127. J Control Release 2001; 76: 27–37
   PubMed Web of Science ®Google Scholar
• Cosgrove D. Echo enhancers and ultrasound imaging. Eur J Radiol 1997; 26: 64–76
   PubMedGoogle Scholar
• Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase Inhibitors and cancer: Trials and tribulations. Science 2002; 295(5564)2387–92
   PubMed Web of Science ®Google Scholar
• Davidsen J, Jørgensen K, Andresen TL, Mouritsen OG. Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue. Biochim Biophys Acta 2003; 1609: 95–101
   PubMed Web of Science ®Google Scholar
• Davidsen J, Vermehren C, Frokjaer S, Mouritsen OG, Jørgensen K. Drug delivery by phospholipase A2 degradable liposomes. Int J Pharm 2001; 214: 67–9
   PubMed Web of Science ®Google Scholar
• Deenen L, Haas G, Heemskerk C. Hydrolysis of synthetic phosphatides by clostridium welchi phosphatides. Biochem Biophys Res Commun 1961; 4: 183–7
   PubMedGoogle Scholar
• Derycke ASL, Witte PAM. Liposomes for photodynamic therapy. Adv Drug Deliv Rev 2004; 56: 17–30
   PubMed Web of Science ®Google Scholar
• Drummond DC, Zignani M, Leroux JC. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 2000; 39: 409–60
   PubMed Web of Science ®Google Scholar
• Ellerbroek SM, Hudson LG, Stack MS. Proteinase requirements of epidermal growth factor-induced ovarian cell invasion. Int J Cancer 1998; 78: 331–7
   PubMedGoogle Scholar
• Elegbede AI, Banerjee J, Hanson AJ, Tobwala S, Ganguli B, Wang R, Lu X, Srivastave DK, Mallik S. Mechanistic studies on the triggered release of liposomal contents by matrix metalloproteinase-9. J Am Chem Soc 2008; 130(32)10633–42
   PubMed Web of Science ®Google Scholar
• Evjen TJ, Nilssen EA, Flower RA, Røgnvaldsson S, Brandl M, Fossheim SL. Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound. Int J Pharm 2011; 406: 114–16
   PubMed Web of Science ®Google Scholar
• Foged C, Nielsen HM, Frokjaer S. Liposomes for phospholipase A2 triggered SiRNA release: Preparation and in vitro test. Int J Pharm 2007; 331: 160–6
   PubMed Web of Science ®Google Scholar
• Francis RJ, Sharma SK, Springer C, Green AJ, Hope-Stone LD, Sena L, Martin J, Adamson KL, Robbin A, Gumbrell L, et al. A phase I trial of Antibody Directed Prodrug Therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. Br J Cancer 2002; 87: 600–7
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Drug entrapment in liposomes. FEBS Lett 1973; 36: 292–6
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Overview of liposomes. J Antimicrob Chem 1991; 28: 39–48
   PubMed Web of Science ®Google Scholar
• Gregoriadis G, Senior J. The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from circulation. FEBS Lett 1980; 119(1)43–6
   PubMedGoogle Scholar
• Hesketh TR, Payne SN, Humphrey JH. Complement and phospholipase C lysis of lipid membranes. Immunology 1972; 23: 705–11
   PubMedGoogle Scholar
• Huang S-L. Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev 2008; 60: 1167–76
   PubMed Web of Science ®Google Scholar
• Huang L, Connor J. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive liposomes. J Cell Biol 1985; 101: 582–9
   PubMedGoogle Scholar
• Huang S-L, Macdonald RC. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta 2004; 1665: 134–41
   PubMed Web of Science ®Google Scholar
• Kasgaard T, Andresen TL, Jensen SS, Holte OR, Jensen LT, Jørgensen K. Liposome containing alkylated methotrexate analogues for Phospholipase A2 mediated tumour targeted delivery. Chem Phys Lipids 2009; 157: 94–103
   PubMedGoogle Scholar
• Kaur R, Morris R, Bencsik M, Vangala A, Rades T, Perrie Y. Development of a novel magnetic resonance imaging contrast agent for pressure measurements using lipid-coated microbubbles. J Biomed Nanotechnol 2009; 5(6)1–9
   PubMedGoogle Scholar
• Kilbanov AL, Shevechenko TI, Raju BI, Seip R, Chin CT. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: A tool for targeted delivery. J Control Release 2010; 148: 13–17
   PubMedGoogle Scholar
• Kim CK, Park KM. Liposome immunoassay (LIA) for gentamicin using phospholipase C. J Immunol Methods 1994; 170: 225–31
   PubMedGoogle Scholar
• Kirby C, Clarke J, Gregoriadis G. Effect of cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 1980; 186: 591–8
   PubMed Web of Science ®Google Scholar
• Kono K. Thermosensitive polymer-modified liposomes. Adv Drug Deliv Rev 2001; 53: 307–19
   PubMed Web of Science ®Google Scholar
• Kono K, Nakai R, Morimoto K, Takagishi T. Thermosensitive polymer-modified liposomes that release contents around physiological temperature. Biochim Biophys Acta 1999; 1416: 239–50
   PubMed Web of Science ®Google Scholar
• Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68–69: 3–58
   PubMed Web of Science ®Google Scholar
• Lasic DD. Novel applications of liposomes. Trends Biotechnol 1998; 16: 307–21
   PubMed Web of Science ®Google Scholar
• Lee R, Wang S, Low PS. Measurement of endosome pH following folate receptor-mediated endocytosis. Biochim Biophys Acta 1996; 1312: 237–42
   PubMed Web of Science ®Google Scholar
• Li W, Nicol F, Szoka FC, Jr. Gala: A designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 2004; 56: 967–85
   PubMed Web of Science ®Google Scholar
• Lian T, Ho JYR. Trends and developments in liposome drug delivery systems. J Pharm Sci 2001; 90: 667–79
   PubMed Web of Science ®Google Scholar
• Liao R-Z, Yu J-G, Himo F. Reaction mechanism of the trinuclear zinc enzyme phospholipase C: A density functional theory study. J Phys Chem B 2010; 114: 2533–40
   PubMedGoogle Scholar
• Lim SJ, Kim CK. Homogenous liposome Immunoassay for insulin using phospholipase C from Clostridium perfringens. Anal Biochem 1997; 247: 89–95
   PubMed Web of Science ®Google Scholar
• Long C, Maguire MF. The structure of naturally occurring Phosphoglycerides: The evidence from a study of the action of phospholipase C. Biochem J 1954; 57: 223–6
   PubMedGoogle Scholar
• Macfarlane MG, Knight B. The biochemistry of bacterial toxins; The lecithinase activity of C. Welchii Toxins. Biochem J 1941; 35: 884–902
   Google Scholar
• Mann J. Natural products in cancer chemotherapy: Past, present and future. Nature Rev Cancer 2002; 2: 143–8
   PubMed Web of Science ®Google Scholar
• Marxer E, Brüßler J, Becker A, Schümmelfeder J, Schubert R, Nimsky C, Bakowsky U. Development and characterisation of new nanoscaled ultrasound active lipid dispersions as contrast agents. Eur J Pharm Biopharm 2011; 77: 430–7
   PubMed Web of Science ®Google Scholar
• Matsumara Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumour agent smancs. Cancer Res 1986; 46: 6387–92
   PubMed Web of Science ®Google Scholar
• Meers P. Enzyme-activated targeting of liposomes. Adv Drug Deliv Rev 2001; 53: 265–72
   PubMed Web of Science ®Google Scholar
• Morris RH, Bencsik M, Nestle N, Galvosas P, Fairhurst D, Vangala A, Perrie Y, McHale G. Robust spatially resolved pressure measurements using MRI with novel buoyant advection-free preparations of stable microbubbles in polysaccharide gels. J Magn Reson 2008; 193(2)159–67
   PubMed Web of Science ®Google Scholar
• Murukami M, Taketomi Y, Girard C, Yamamoto K, Lambeau G. Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice. Biochimie 2010; 92: 561–82
   PubMedGoogle Scholar
• Needham D, Dewhirst MW. The development and testing of a new temperature- sensitive drug delivery system for the treatment of solid tumours. Adv Drug Deliv Rev 2001; 53: 285–305
   PubMed Web of Science ®Google Scholar
• Pak CC, Ali S, Andrew S, Meers J, Meers P. Triggerable liposomal fusion by enzyme cleavage of a novel peptide-lipid conjugate. Biochim Biophys Acta 1998; 1372: 13–27
   PubMed Web of Science ®Google Scholar
• Primeau AJ, Rendon A, Hedley D, Lilge L, Tannock IF. The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 2005; 11(24 Pt. 1)8782–8
   PubMed Web of Science ®Google Scholar
• Rhodes CT, Vemuri S. Preparation and characterization of liposomes as therapeutic delivery systems: A review. Pharm Acta Helev 1995; 70: 95–111
   PubMedGoogle Scholar
• Rongen HAH, Bult A, Bennekom WPV. Liposomes and immunoassays. J Immunol Methods 1997; 204: 105–33
   PubMed Web of Science ®Google Scholar
• Ruiz-Argüello MB, Goñi FM, Alonso A. Phospholipase C hydrolysis of phospholipids in bilayers of mixed lipid compositions. Biochemistry 1998; 37: 11621–8
   PubMed Web of Science ®Google Scholar
• Sarkar NR, Rosendahl TT, Krueger AB, Banerjee AL, Benton K, Malik S, Srivastave DK. “Uncorking” of liposomes by matrix metalloproteinase-9. Chem Commun 2005; 8: 999–1001
   Google Scholar
• Schroeder A, Kost J, Barenholz Y. Ultrasound, liposomes and drug delivery: Principles for using ultrasound to control the release of drug from liposomes. Chem Phys Lipids 2009a; 162: 1–16
   PubMed Web of Science ®Google Scholar
• Schroeder A, Honen R, Turjeman K, Gabizon A, Kost J, Barenholz Y. Ultrasound triggered release of cisplatin from liposomes in murine tumours. J Control Release 2009b; 137: 63–8
   PubMed Web of Science ®Google Scholar
• Senior J, Gregoriadis G. Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of phospholipid and cholesterol components. Life Sci 1982; 30(24)2123–36
   PubMedGoogle Scholar
• Shi G, Guo W, Stephenson SM, Lee RJ. Efficient intracellular drug and gene delivery using folate-receptor-targeted pH sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release 2002; 80: 309–19
   PubMed Web of Science ®Google Scholar
• Shum P, Kim J-M, Thompson DH. Phototriggering of liposomal drug delivery systems. Adv Drug Deliv Rev 2001; 53: 273–84
   PubMed Web of Science ®Google Scholar
• Simoes S, Moreira JN, Fonseca C, Duzgunes N, Lima MCP. On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev 2004; 56: 947–65
   PubMed Web of Science ®Google Scholar
• Smith AM, Harris JJ, Shelton RM, Perrie Y. 3D culture of bone-derived cells immobilised in alginate following light- triggered gelation. J Control Release 2007; 119: 94–101
   PubMedGoogle Scholar
• Smith B, Lyakhov I, Loomis K, Needle D, Baxa U, Yavlovich A, Capal J, Blumenthal R, Puri A. Hyperthermia – triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affibody (ZHER2-GC-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes). J Control Release 2011; 153(2)187–94
   PubMed Web of Science ®Google Scholar
• Storm G, Crommelin JA. Liposomes: Quo vadis?. PSTT 1998; 1(1)19–31
   Google Scholar
• Vangala AK, Morris RH, Bencsik M, Perrie Y. Preparation and characterisation of gas-filled liposomes: Can they improve oil recovery. J Liposome Res 2007; 17(3)263–72
   PubMedGoogle Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry. Circ Res 2003; 92: 827–39
   PubMed Web of Science ®Google Scholar
• Winter ND, Murphy RKJ, Halloran TVO, Schatz GC. Development and modelling of arsenic – trioxide-loaded thermosensitive liposomes for anticancer drug delivery. J Liposome Res 2011; 21: 106–15
   PubMed Web of Science ®Google Scholar
• Yavlovich A, Singh A, Blumenthal R, Puri A. A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vesicles for delivery of doxorubicin to cells. Biochim Biophys Acta 2011; 1808: 117–26
   PubMed Web of Science ®Google Scholar
• Zasadzinski JA, Wong B, Forbes N, Braun G, Wu G. Novel methods of enhanced retention in and rapid, targeted release from liposomes. Curr Opin Colloid Interface Sci 2011; 16: 203–14
   PubMed Web of Science ®Google Scholar
• Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD. Secretory phospholipase A2 responsive liposomes. J Pharm Sci 2011; 100(8)3146–59
   PubMed Web of Science ®Google Scholar